SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of...
LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- During CES 2025, Microsoft Greater China held a specialized event themed "Be AI Ready, Win Globally," focusing...
MANILA, Philippines, Jan. 14, 2025 /PRNewswire/ -- UNI-PIPC (UNI-President Information Philippines Corp.), a new IT solutions provider and subsidiary of Uni-President Group., today announced...
Local artist Vika Cheng meticulously designed and handcrafted giant paper coloured carp to send blessings to the public
The installation features interactive...
KUALA LUMPUR, Malaysia, Jan. 14, 2025 /PRNewswire/ -- The Malaysian Society for Quality in Health (MSQH), a leading national healthcare accreditation body dedicated to...
HO CHI MINH CITY, Vietnam, Jan. 14, 2025 /PRNewswire/ -- GlobalTix, Asia's leading ticketing and marketplace distribution platform, has been named "Growth Partner of...
MELBOURNE, Australia, Jan. 14, 2025 /PRNewswire/ -- As Australia's retail trading market matures, the focus is shifting beyond regulatory compliance to a broader culture...